Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 216544

In scope icon M 2
QID 216544 (Type "216544" in App Search)
A 27-year-old woman, G2P1 at 17 weeks gestation presents to the clinic for a prenatal visit. She reports no regular prenatal care prior to this. Her past medical history is notable for untreated HIV infection. She reports using methamphetamine regularly and has 4-5 drinks of alcohol per week. Her temperature is 98.3°F (36.8°C), blood pressure is 116/70 mmHg, pulse is 75/min, and respirations are 16/min. Pelvic examination shows a uterus consistent in size with a 17-week gestation. Maternal serum studies show elevated alpha-fetoprotein. Serum concentrations of beta-human chorionic gonadotropin, estriol, and inhibin A are normal. Amniotic fluid levels of acetylcholinesterase (AChE) are elevated on amniotic fluid analysis. Which of the following maternal interventions could have most likely prevented this fetus’s condition?

Blood glucose level optimization

0%

0/0

Cessation of alcohol use

0%

0/0

Cessation of amphetamine use

0%

0/0

Combined antiretroviral therapy

0%

0/0

Folic acid supplementation

0%

0/0

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient without previous prenatal care presents with elevated serum levels of alpha-fetoprotein and elevated amniotic fluid levels of AChE, most suggestive of a neural tube defect. Neural tube defects can be prevented with maternal supplementation of folic acid, which is necessary for neural tube closure.

Neural tube defects are congenital abnormalities that occur due to failure of neural tube closure between the third and fourth weeks of development. Folic acid (folate) is necessary for this process, and thus folic acid supplementation is necessary prior to conception. The recommended dose of folic acid supplementation in low-risk pregnancies is 0.4-0.8 mg daily. Drugs that inhibit folate metabolism or action, such as trimethoprim or methotrexate, can increase risk of neural tube defects and are thus contraindicated during pregnancy. Genetic mutations in folate metabolism enzymes such as methylenetetrahydrofolate reductase (MTHFR) can also predispose patients to neural tube defects. In utero surgical repair of these defects is an important novel treatment to reduce the morbidity from these disorders.

Copp et al. review the molecular and developmental mechanisms underpinning neural tube defects. They discuss how primary prevention through folate supplementation has dramatically reduced the prevalence of these disorders. They recommend using in-utero corrective measures to decrease the neurological deficits seen in these children.

Incorrect Answers:
Answer 1: Blood glucose level optimization can prevent the effects of maternal hyperglycemia, which include macrosomia, fetal hyperinsulinemia, and organomegaly. Severe hyperglycemia during early fetal development (e.g., in maternal diabetes) can increase the risk of neural tube defects, but this is not the most likely cause of a neural tube defect in this woman with no history of diabetes.

Answer 2: Cessation of alcohol use can prevent fetal alcohol syndrome, which is characterized by intellectual disability, microcephaly, facial abnormalities (e.g., smooth philtrum, small palpebral fissures), and heart defects. Alcohol is not associated with neural tube defects.

Answer 3: Cessation of amphetamine use could prevent many obstetric complications, including growth restriction, spontaneous abortion, preeclampsia, and preterm birth. However, this patient presents with elevated serum alpha-fetoprotein and amniotic fluid AChE, indicative of a neural tube defect. Amphetamine use is not associated with neural tube defects.

Answer 4: Combined antiretroviral therapy, particularly zidovudine, can prevent the transplacental transmission of HIV. Fetal HIV does not cause neural tube defects but instead leads to early onset and frequent childhood infections. Treatment is with antiretroviral therapy in the neonatal period.

Bullet Summary:
Elevated serum alpha-fetoprotein and amniotic fluid AChE are indicative of a neural tube defect, which can be prevented with maternal folic acid supplementation.

REFERENCES (1)
Authors
Rating
Please Rate Question Quality

0.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(0)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options